We have located links that may give you full text access.
Case Reports
Journal Article
Intermittent haemodialysis and sustained low-efficiency dialysis (SLED) for acute theophylline toxicity.
Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology 2015 September
INTRODUCTION: Theophylline overdose can result in significant cardiovascular and neurologic toxicity and is potentially fatal. Clearance of theophylline can be enhanced by the administration of multiple-dose activated charcoal (MDAC) and extracorporeal elimination techniques. We report a case of severe theophylline toxicity initially treated with MDAC and intermittent haemodialysis. Subsequent to this, sustained low-efficiency dialysis (SLED) was undertaken. This is a prolonged renal replacement therapy that uses blood and dialysate flow rates between those of intermittent haemodialysis and continuous renal replacement therapy.
CASE REPORT: A 61-year-old man presented following ingestion of 24 g of theophylline SR (300 mg/kg), 240 mg of diazepam and 2 g of gabapentin. He required intubation and developed a supraventricular tachycardia treated with esmolol, but suffered no seizures. Serum theophylline concentration peaked at 636 μmol/L (55-110) at 9.5 h post-ingestion. Intermittent haemodialysis was performed for 4 h and resulted in a theophylline extraction ratio of 0.57 with elimination half-life of 2.3 h. SLED was subsequently performed on two occasions for 7 h. Theophylline extraction ratio ranged from 0.46 (half-life 5.3 h during the first cycle) to 0.61 (half-life 10.6 h during the second cycle). After cessation of SLED, elimination half-life was 26 h. The patient made an uneventful recovery.
DISCUSSION: Intermittent haemodialysis is the current recommended extracorporeal technique for enhancing theophylline elimination in the absence of charcoal haemoperfusion. However, SLED produced similar apparent extraction ratios with longer associated elimination half-life for theophylline than for intermittent haemodialysis. SLED is undertaken by intensive care unit (ICU) staff and may be a useful extracorporeal elimination technique in cases where access to intermittent haemodialysis, requiring specialist dialysis nursing staff, is limited or may be delayed.
CASE REPORT: A 61-year-old man presented following ingestion of 24 g of theophylline SR (300 mg/kg), 240 mg of diazepam and 2 g of gabapentin. He required intubation and developed a supraventricular tachycardia treated with esmolol, but suffered no seizures. Serum theophylline concentration peaked at 636 μmol/L (55-110) at 9.5 h post-ingestion. Intermittent haemodialysis was performed for 4 h and resulted in a theophylline extraction ratio of 0.57 with elimination half-life of 2.3 h. SLED was subsequently performed on two occasions for 7 h. Theophylline extraction ratio ranged from 0.46 (half-life 5.3 h during the first cycle) to 0.61 (half-life 10.6 h during the second cycle). After cessation of SLED, elimination half-life was 26 h. The patient made an uneventful recovery.
DISCUSSION: Intermittent haemodialysis is the current recommended extracorporeal technique for enhancing theophylline elimination in the absence of charcoal haemoperfusion. However, SLED produced similar apparent extraction ratios with longer associated elimination half-life for theophylline than for intermittent haemodialysis. SLED is undertaken by intensive care unit (ICU) staff and may be a useful extracorporeal elimination technique in cases where access to intermittent haemodialysis, requiring specialist dialysis nursing staff, is limited or may be delayed.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2025 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app